MedPath

Evaluation of the Performance of Different Daily Disposable Lens Designs in Habitual Soft Contact Lens Wearers

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: stenfilcon A - (Test lens)
Device: kalifilcon A - (Control Lens)
Registration Number
NCT04668989
Lead Sponsor
Coopervision, Inc.
Brief Summary

The main objective of the study is to refit existing soft lens wearers with two different daily disposable contact lens types, Lens A and Lens B, to determine their performance after one week of wear.

Detailed Description

This study is a prospective, bilateral eye, double-masked, randomized, 1-week cross-over, daily-wear design involving two different daily disposable lens types. Each lens type will be worn for approximately one week, during which participants record their subjective lens-wear experience.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  1. Is at least 18 years of age and has full legal capacity to volunteer;
  2. Has read and signed an information consent letter;
  3. Self reports having a full eye examination in the previous two years;
  4. Anticipates being able to wear the study lenses for at least 8 hours a day, 7 days a week;
  5. Is willing and able to follow instructions and maintain the appointment schedule;
  6. Habitually wears soft contact lenses, for the past 3 months minimum;
  7. Has refractive astigmatism no higher than -0.75DC in each eye;
  8. Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available lens parameters are sphere -1.00 to -6.00D, 0.25D steps).
Exclusion Criteria
  1. Is participating in any concurrent clinical or research study;
  2. Habitually wears one of the study contact lenses;
  3. Has any known active* ocular disease and/or infection that contraindicates contact lens wear;
  4. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  5. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
  6. Has known sensitivity to the diagnostic sodium fluorescein used in the study;
  7. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
  8. Has undergone refractive error surgery or intraocular surgery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
kalifilcon A - (Control Lens)stenfilcon A - (Test lens)Subjects will be randomized to wear control lenses for one week then cross-over to the test lenses for one week.
kalifilcon A - (Control Lens)kalifilcon A - (Control Lens)Subjects will be randomized to wear control lenses for one week then cross-over to the test lenses for one week.
stenfilcon A - (Test lens)stenfilcon A - (Test lens)Subjects will be randomized to wear test lenses for one week then cross-over to the control lenses for one week.
stenfilcon A - (Test lens)kalifilcon A - (Control Lens)Subjects will be randomized to wear test lenses for one week then cross-over to the control lenses for one week.
Primary Outcome Measures
NameTimeMethod
Lens Wettability1 week

Lens wettability on a 0 to 4 descriptive scale, 0.5 steps (0 - Very poor: Immediately displaying non-wetting areas on the lens surface, immediate drying time, 1 - Poor: Irregular surface appearance, drying time \<\< blink time, 2 - Acceptable: Smooth surface appearance immediately after the blink becoming irregular after a while, drying time ≤ blink time, 3 - Good: Typical soft lens appearance with long drying time, 4 - Excellent: Appearance similar to a healthy cornea with very long drying time)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Complete Eye Care of Medina

🇺🇸

Medina, Minnesota, United States

Athens Eye Care

🇺🇸

Athens, Ohio, United States

Nittany Eye Associates

🇺🇸

College, Pennsylvania, United States

Sacco Eye Group, PLLC

🇺🇸

Vestal, New York, United States

© Copyright 2025. All Rights Reserved by MedPath